{"id":"https://openalex.org/W2170210469","doi":"https://doi.org/10.1161/circresaha.111.300367","title":"Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans","display_name":"Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans","publication_year":2013,"publication_date":"2013-03-30","ids":{"openalex":"https://openalex.org/W2170210469","doi":"https://doi.org/10.1161/circresaha.111.300367","mag":"2170210469","pmid":"https://pubmed.ncbi.nlm.nih.gov/23542898"},"language":"en","primary_location":{"id":"doi:10.1161/circresaha.111.300367","doi":"https://doi.org/10.1161/circresaha.111.300367","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circresaha.111.300367","pdf_url":null,"source":{"id":"https://openalex.org/S10652568","display_name":"Circulation Research","issn_l":"0009-7330","issn":["0009-7330","1524-4571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103758244","display_name":"Mark J. Graham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark J. Graham","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Mark J. Graham From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Mark J. Graham From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102877391","display_name":"Richard G. Lee","orcid":"https://orcid.org/0000-0003-1738-1746","observed_orcids":["https://orcid.org/0000-0003-1738-1746"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard G. Lee","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Richard G. Lee From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Richard G. Lee From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Thomas A. Bell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas A. Bell","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Thomas A. BellIII From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Thomas A. BellIII From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070917564","display_name":"Wuxia Fu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wuxia Fu","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Wuxia Fu From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Wuxia Fu From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031102353","display_name":"Adam E. Mullick","orcid":"https://orcid.org/0000-0003-4600-961X","observed_orcids":["https://orcid.org/0000-0003-4600-961X"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam E. Mullick","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Adam E. Mullick From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Adam E. Mullick From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080535370","display_name":"Veronica J. Alexander","orcid":"https://orcid.org/0000-0003-3729-5749","observed_orcids":["https://orcid.org/0000-0003-3729-5749"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Veronica J. Alexander","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Veronica J. Alexander From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Veronica J. Alexander From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Walter Singleton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Walter Singleton","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Walter Singleton From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Walter Singleton From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112876791","display_name":"N. Viney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nick Viney","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Nick Viney From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Nick Viney From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056554811","display_name":"Richard S. Geary","orcid":"https://orcid.org/0000-0002-6308-3179","observed_orcids":["https://orcid.org/0000-0002-6308-3179"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Geary","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Richard Geary From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Richard Geary From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113806917","display_name":"John Q. Su","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Su","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","John Su From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"John Su From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039227038","display_name":"Brenda F. Baker","orcid":"https://orcid.org/0000-0001-8586-768X","observed_orcids":["https://orcid.org/0000-0001-8586-768X"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brenda F. Baker","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Brenda F. Baker From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Brenda F. Baker From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039324932","display_name":"Jennifer Burkey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Burkey","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Jennifer Burkey From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Jennifer Burkey From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077755519","display_name":"Stanley T. Crooke","orcid":"https://orcid.org/0000-0002-4260-1520","observed_orcids":["https://orcid.org/0000-0002-4260-1520"]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stanley T. Crooke","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Stanley T. Crooke From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Stanley T. Crooke From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041988426","display_name":"Rosanne M. Crooke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800035258","display_name":"Ionis Pharmaceuticals (United States)","ror":"https://ror.org/00t8bew53","country_code":"US","type":"company","lineage":["https://openalex.org/I2800035258"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rosanne M. Crooke","raw_affiliation_strings":["From Isis Pharmaceuticals, Carlsbad, CA","Rosanne M. Crooke From Isis Pharmaceuticals, Carlsbad, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]},{"raw_affiliation_string":"Rosanne M. Crooke From Isis Pharmaceuticals, Carlsbad, CA","institution_ids":["https://openalex.org/I2800035258"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5102877391","https://openalex.org/A5103758244"],"corresponding_institution_ids":["https://openalex.org/I2800035258"],"apc_list":null,"apc_paid":null,"fwci":29.8864,"has_fulltext":true,"cited_by_count":382,"citation_normalized_percentile":{"value":0.99780413,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"112","issue":"11","first_page":"1479","last_page":"1490"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.03959999978542328,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apolipoprotein-c-iii","display_name":"apolipoprotein C-III","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9879999756813049},{"id":"https://openalex.org/keywords/plasma-triglycerides","display_name":"plasma triglycerides","score":0.9359999895095825},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/triglyceride-lowering-therapy","display_name":"triglyceride-lowering therapy","score":0.6349999904632568},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.6000000238418579},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7559999823570251},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.6439999938011169},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.9120000004768372}],"concepts":[{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.7585533857345581},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.584763765335083},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.5792586207389832},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5350896716117859},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5209257006645203},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5191773176193237},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.5184733271598816},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4524118900299072},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3911810517311096},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3324284851551056}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008253","descriptor_name":"Macaca mulatta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011924","descriptor_name":"Rats, Zucker","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011973","descriptor_name":"Receptors, LDL","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053305","descriptor_name":"Apolipoprotein C-III","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053305","descriptor_name":"Apolipoprotein C-III","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D053305","descriptor_name":"Apolipoprotein C-III","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1161/circresaha.111.300367","doi":"https://doi.org/10.1161/circresaha.111.300367","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circresaha.111.300367","pdf_url":null,"source":{"id":"https://openalex.org/S10652568","display_name":"Circulation Research","issn_l":"0009-7330","issn":["0009-7330","1524-4571"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation Research","raw_type":"journal-article"},{"id":"pmid:23542898","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23542898","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation research","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":71,"referenced_works":["https://openalex.org/W1487880507","https://openalex.org/W1889257304","https://openalex.org/W1910561012","https://openalex.org/W1916117934","https://openalex.org/W1924220480","https://openalex.org/W1965740352","https://openalex.org/W1965793369","https://openalex.org/W1976428272","https://openalex.org/W1976476281","https://openalex.org/W1976791053","https://openalex.org/W1977040679","https://openalex.org/W1978470249","https://openalex.org/W1982477772","https://openalex.org/W1986988638","https://openalex.org/W1992026272","https://openalex.org/W2015836295","https://openalex.org/W2025242285","https://openalex.org/W2026500861","https://openalex.org/W2026674552","https://openalex.org/W2026934511","https://openalex.org/W2029164903","https://openalex.org/W2034235812","https://openalex.org/W2036747551","https://openalex.org/W2037283919","https://openalex.org/W2041953515","https://openalex.org/W2042140336","https://openalex.org/W2054622068","https://openalex.org/W2054930955","https://openalex.org/W2061092005","https://openalex.org/W2061100095","https://openalex.org/W2072567581","https://openalex.org/W2072967808","https://openalex.org/W2084500770","https://openalex.org/W2088265538","https://openalex.org/W2089187422","https://openalex.org/W2090004331","https://openalex.org/W2097086470","https://openalex.org/W2097893773","https://openalex.org/W2106343349","https://openalex.org/W2107904682","https://openalex.org/W2112284378","https://openalex.org/W2113680815","https://openalex.org/W2116648398","https://openalex.org/W2122475146","https://openalex.org/W2125806034","https://openalex.org/W2127958304","https://openalex.org/W2128293328","https://openalex.org/W2128458878","https://openalex.org/W2130120054","https://openalex.org/W2131037449","https://openalex.org/W2133896415","https://openalex.org/W2134450273","https://openalex.org/W2135484390","https://openalex.org/W2138061818","https://openalex.org/W2139591016","https://openalex.org/W2140828248","https://openalex.org/W2142476549","https://openalex.org/W2143004231","https://openalex.org/W2143340286","https://openalex.org/W2145073911","https://openalex.org/W2149813409","https://openalex.org/W2154006542","https://openalex.org/W2154138159","https://openalex.org/W2154210359","https://openalex.org/W2157668743","https://openalex.org/W2165961239","https://openalex.org/W2168095967","https://openalex.org/W2506210560","https://openalex.org/W2726799618","https://openalex.org/W4245139249","https://openalex.org/W7073611315"],"related_works":["https://openalex.org/W2152176101","https://openalex.org/W4376128675","https://openalex.org/W1202310223","https://openalex.org/W2315899065","https://openalex.org/W4303444510","https://openalex.org/W2069709462","https://openalex.org/W4205868548","https://openalex.org/W2759282637","https://openalex.org/W3019885136","https://openalex.org/W2621005943"],"abstract_inverted_index":{"RATIONALE:":[0],"Elevated":[1],"plasma":[2,34,87,177,217],"triglyceride":[3,35,90,127,149,182],"levels":[4,40],"have":[5,41],"been":[6,42,60],"recognized":[7],"as":[8],"a":[9,29,204],"risk":[10,26,223],"factor":[11,27,32],"for":[12,225],"the":[13,63,68,120,167,191],"development":[14],"of":[15,33,73,123,138,166,181,197],"coronary":[16],"heart":[17],"disease.":[18,227],"Apolipoprotein":[19],"C-III":[20],"(apoC-III)":[21],"represents":[22],"both":[23,124],"an":[24],"independent":[25],"and":[28,47,81,89,96,103,115,126,143,184,202,219],"key":[30],"regulatory":[31],"concentrations.":[36],"Furthermore,":[37],"elevated":[38],"apoC-III":[39,56,74,88,112,125,139,169,198,218],"associated":[43,145],"with":[44,75,146,209],"metabolic":[45],"syndrome":[46],"type":[48],"2":[49,221],"diabetes":[50],"mellitus.":[51],"To":[52,66],"date,":[53],"no":[54,186],"selective":[55,71,121,214],"therapeutic":[57],"agent":[58],"has":[59],"evaluated":[61,104],"in":[62,78,82,105,128,162,173,176,190,199,203,216,236],"clinic.":[64],"OBJECTIVE:":[65],"test":[67],"hypothesis":[69],"that":[70,136],"inhibition":[72,137,196],"antisense":[76,99,170],"drugs":[77],"preclinical":[79,106,130,200],"models":[80,201],"healthy":[83,163,210],"volunteers":[84],"would":[85],"reduce":[86],"levels.":[91],"METHODS":[92],"AND":[93],"RESULTS:":[94],"Rodent-":[95],"human-specific":[97],"second-generation":[98],"oligonucleotides":[100],"were":[101],"identified":[102],"models,":[107],"including":[108],"rats,":[109],"mice,":[110,114],"human":[111,168],"transgenic":[113],"nonhuman":[116],"primates.":[117],"We":[118,133],"demonstrated":[119],"reduction":[122],"all":[129],"pharmacological":[131,230],"evaluations.":[132,193],"also":[134],"showed":[135],"was":[140,160],"well":[141],"tolerated":[142],"not":[144],"increased":[147],"liver":[148],"deposition":[150],"or":[151],"hepatotoxicity.":[152],"A":[153],"double-blind,":[154],"placebo-controlled,":[155],"phase":[156,205],"I":[157,206],"clinical":[158,207,234],"study":[159],"performed":[161],"subjects.":[164,238],"Administration":[165],"drug":[171],"resulted":[172],"dose-dependent":[174],"reductions":[175,215],"apoC-III,":[178],"concomitant":[179],"lowering":[180],"levels,":[183],"produced":[185,212],"clinically":[187],"meaningful":[188],"signals":[189],"safety":[192],"CONCLUSIONS:":[194],"Antisense":[195],"trial":[208],"subjects":[211],"potent,":[213],"triglyceride,":[220],"known":[222],"factors":[224],"cardiovascular":[226],"This":[228],"compelling":[229],"profile":[231],"supports":[232],"further":[233],"investigations":[235],"hypertriglyceridemic":[237]},"counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":16},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":32},{"year":2021,"cited_by_count":20},{"year":2020,"cited_by_count":41},{"year":2019,"cited_by_count":31},{"year":2018,"cited_by_count":30},{"year":2017,"cited_by_count":26},{"year":2016,"cited_by_count":45},{"year":2015,"cited_by_count":41},{"year":2014,"cited_by_count":39},{"year":2013,"cited_by_count":12}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}